Cargando…
Antimutagenic compounds and their possible mechanisms of action
Mutagenicity refers to the induction of permanent changes in the DNA sequence of an organism, which may result in a heritable change in the characteristics of living systems. Antimutagenic agents are able to counteract the effects of mutagens. This group of agents includes both natural and synthetic...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990861/ https://www.ncbi.nlm.nih.gov/pubmed/24615570 http://dx.doi.org/10.1007/s13353-014-0198-9 |
_version_ | 1782312348788195328 |
---|---|
author | Słoczyńska, Karolina Powroźnik, Beata Pękala, Elżbieta Waszkielewicz, Anna M. |
author_facet | Słoczyńska, Karolina Powroźnik, Beata Pękala, Elżbieta Waszkielewicz, Anna M. |
author_sort | Słoczyńska, Karolina |
collection | PubMed |
description | Mutagenicity refers to the induction of permanent changes in the DNA sequence of an organism, which may result in a heritable change in the characteristics of living systems. Antimutagenic agents are able to counteract the effects of mutagens. This group of agents includes both natural and synthetic compounds. Based on their mechanism of action among antimutagens, several classes of compounds may be distinguished. These are compounds with antioxidant activity; compounds that inhibit the activation of mutagens; blocking agents; as well as compounds characterized with several modes of action. It was reported previously that several antitumor compounds act through the antimutagenic mechanism. Hence, searching for antimutagenic compounds represents a rapidly expanding field of cancer research. It may be observed that, in recent years, many publications were focused on the screening of both natural and synthetic compounds for their beneficial muta/antimutagenicity profile. Thus, the present review attempts to give a brief outline on substances presenting antimutagenic potency and their possible mechanism of action. Additionally, in the present paper, a screening strategy for mutagenicity testing was presented and the characteristics of the most widely used antimutagenicity assays were described. |
format | Online Article Text |
id | pubmed-3990861 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-39908612014-04-22 Antimutagenic compounds and their possible mechanisms of action Słoczyńska, Karolina Powroźnik, Beata Pękala, Elżbieta Waszkielewicz, Anna M. J Appl Genet Microbial Genetics · Review Mutagenicity refers to the induction of permanent changes in the DNA sequence of an organism, which may result in a heritable change in the characteristics of living systems. Antimutagenic agents are able to counteract the effects of mutagens. This group of agents includes both natural and synthetic compounds. Based on their mechanism of action among antimutagens, several classes of compounds may be distinguished. These are compounds with antioxidant activity; compounds that inhibit the activation of mutagens; blocking agents; as well as compounds characterized with several modes of action. It was reported previously that several antitumor compounds act through the antimutagenic mechanism. Hence, searching for antimutagenic compounds represents a rapidly expanding field of cancer research. It may be observed that, in recent years, many publications were focused on the screening of both natural and synthetic compounds for their beneficial muta/antimutagenicity profile. Thus, the present review attempts to give a brief outline on substances presenting antimutagenic potency and their possible mechanism of action. Additionally, in the present paper, a screening strategy for mutagenicity testing was presented and the characteristics of the most widely used antimutagenicity assays were described. Springer Berlin Heidelberg 2014-03-11 2014 /pmc/articles/PMC3990861/ /pubmed/24615570 http://dx.doi.org/10.1007/s13353-014-0198-9 Text en © The Author(s) 2014 https://creativecommons.org/licenses/by/2.0/ Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. |
spellingShingle | Microbial Genetics · Review Słoczyńska, Karolina Powroźnik, Beata Pękala, Elżbieta Waszkielewicz, Anna M. Antimutagenic compounds and their possible mechanisms of action |
title | Antimutagenic compounds and their possible mechanisms of action |
title_full | Antimutagenic compounds and their possible mechanisms of action |
title_fullStr | Antimutagenic compounds and their possible mechanisms of action |
title_full_unstemmed | Antimutagenic compounds and their possible mechanisms of action |
title_short | Antimutagenic compounds and their possible mechanisms of action |
title_sort | antimutagenic compounds and their possible mechanisms of action |
topic | Microbial Genetics · Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990861/ https://www.ncbi.nlm.nih.gov/pubmed/24615570 http://dx.doi.org/10.1007/s13353-014-0198-9 |
work_keys_str_mv | AT słoczynskakarolina antimutageniccompoundsandtheirpossiblemechanismsofaction AT powroznikbeata antimutageniccompoundsandtheirpossiblemechanismsofaction AT pekalaelzbieta antimutageniccompoundsandtheirpossiblemechanismsofaction AT waszkielewiczannam antimutageniccompoundsandtheirpossiblemechanismsofaction |